Balance Disorders in People with History of COVID-19 in Light of Posturographic Tests.

Publication date: Jul 03, 2023

Coronavirus disease-19 (COVID-19), resulting from infection with the SARS-CoV-2 virus, causes not only flu-like symptoms, such as fever, aches, or a dry cough, but also affects the sensory system, leading to a loss of smell and taste or to neurological deficits in the shape of balance disorders and dizziness. Our research aimed to assess the prevalence of balance disorders in patients who had suffered COVID-19. The study group consisted of 73 subjects with a history of SARS-CoV-2 infection. The control group consisted of 50 healthy people with similar demographics. A balance analysis was performed on a tensometric platform, using the Romberg test. Statistically significant differences between the results of the study group and the control group were obtained in the evaluation of the length of body sways and the area of gravity center, both with open and closed eyes, and in the case of maximum body sways with open eyes. Patients who have suffered COVID-19 may suffer from balance disorders detectable by posturographic tests.

Open Access PDF

Concepts Keywords
Coronavirus balance
Covid coronavirus
Disorders COVD-19
Dry dizziness
Flu posturography

Semantics

Type Source Name
drug DRUGBANK Isoxaflutole
disease IDO history
disease MESH COVID-19
disease MESH infection
disease MESH causes
pathway REACTOME SARS-CoV-2 Infection
disease MESH acute respiratory distress syndrome
disease MESH pneumonia
disease MESH sequelae
disease MESH vertigo
disease IDO symptom
disease MESH presyncope
drug DRUGBANK Coenzyme M
disease MESH gait
disease VO organ
disease IDO blood
disease MESH encephalitis
disease MESH encephalopathy
disease MESH cerebrovascular disease
disease IDO process
disease MESH labyrinthitis
disease MESH otitis media
disease MESH vestibular neuritis
drug DRUGBANK Dimercaprol
disease MESH taste disorders
disease MESH neuromuscular diseases
disease MESH sensory disorders
disease MESH aids
disease MESH abnormalities
disease VO device
drug DRUGBANK Creatinolfosfate
disease VO efficiency
disease MESH hypertension
disease MESH sleep disorders
disease MESH death
drug DRUGBANK Chlordiazepoxide
disease MESH syndrome
disease MESH chronic obstructive pulmonary disease
disease VO frequency
disease MESH hearing loss
disease MESH tinnitus
disease VO report
disease VO nose
disease MESH Postural orthostatic tachycardia syndrome
disease VO volume
disease VO effectiveness
disease MESH post acute COVID 19 syndrome

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *